BlackRock Institutional Trust’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $481K | Buy |
1,375
+24
| +2% | +$8.4K | ﹤0.01% | 3459 |
|
|
2016
Q3 | $543K | Buy |
1,351
+112
| +9% | +$45K | ﹤0.01% | 3455 |
|
|
2016
Q2 | $737K | Buy |
1,239
+721
| +139% | +$429K | ﹤0.01% | 3404 |
|
|
2016
Q1 | $261K | Hold |
518
| – | – | ﹤0.01% | 3552 |
|
|
2015
Q4 | $343K | Hold |
518
| – | – | ﹤0.01% | 3556 |
|
|
2015
Q3 | $245K | Hold |
518
| – | – | ﹤0.01% | 3604 |
|
|
2015
Q2 | $294K | Buy |
518
+280
| +118% | +$159K | ﹤0.01% | 3571 |
|
|
2015
Q1 | $2.03M | Buy |
238
+197
| +480% | +$1.68M | ﹤0.01% | 3101 |
|
|
2014
Q4 | $364K | Hold |
41
| – | – | ﹤0.01% | 3538 |
|
|
2014
Q3 | $195K | Sell |
41
-25
| -38% | -$119K | ﹤0.01% | 3597 |
|
|
2014
Q2 | $474K | Sell |
66
-126
| -66% | -$905K | ﹤0.01% | 3559 |
|
|
2014
Q1 | $1.03M | Buy |
+192
| New | +$1.03M | ﹤0.01% | 3393 |
|